Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications. (2021)
Attributed to:
Interrogating ITGA11 signalling in rodent and human for targeted anti-fibrotic therapy in liver fibrosis.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s11892-021-01377-5
PubMed Identifier: 33544287
Publication URI: http://europepmc.org/abstract/MED/33544287
Type: Journal Article/Review
Volume: 21
Parent Publication: Current diabetes reports
Issue: 3
ISSN: 1534-4827